Image Source: AsiaOne
Cogstate Expands Executive Team with Key Scientific Appointments Chris Edgar named Chief Science Officer and Paul Maruff named Chief Innovation Officer GlobeNewswire October 01, 2020 Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul Maruff, PhD as Chief Innovation Officer. These appointments represent an expansion of the executive leadership team with strengthened scientific capacity as the company continues to meet the growing demand for transformative innovations in clinical trials and healthcare. As Chief Science Officer, Dr. Edgar will continue to advise Cogstate customers on clinical endpoint strategy and will set the strategic vision for Cogstate’s global scientific services. He will lead a team of clinical experts focused on the optimization, execution and analyses of cognitive and behavioral assessments and related data quality assurance solutions for improved signal detection and excellence in trial design and conduct.